Anthony Deboer

Anthony DeBoer is a highly experienced individual who currently holds the position of Vice President, Business Development at Synaffix BV. With a background in biotechnology, Anthony has successfully managed tech out-licensing deals worth over $10 billion with various companies such as Innovent Biologics, Amgen, and MacroGenics. Prior to their current role, Anthony held positions at ALLOZYNE and Stanford Institute for Stem Cell Biology and Regenerative Medicine. Anthony is currently pursuing further education at Harvard Business School, adding to their impressive academic background.